Daily Alpha · Reddit
· Premarket Alpha · by Buzzberg Research
Themes on this desk
Neocloud debt / AI overbuild
Retail is split on CoreWeave: one camp buys the $55 break as a contrarian bet, another sees upgrades as an institutional exit and watches sub-$50; a separate thread expects a 2027 compute overbuild and stays long GOOGL/AMZN into April 2027.
Highest engagement
by score · day changeModerna's Phase 3 DMFS hazard ratio worsened versus Phase 2
A wallstreetbets post noted Moderna's Phase 3 distant metastasis-free survival hazard ratio of 0.62 is worse than the 0.35-0.41 seen in Phase 2, arguing the efficacy signal is weaker than headline results imply. It calls DMFS a more meaningful predictor of overall survival.
MRNA DMFS HR degrades from 0.34 to 0.62 Distant metastasis-free survival (DMFS) is a more meaningful predictor of overall survival
It gives a specific clinical metric for judging the efficacy signal.
Watch Watch overall survival and additional tumor-type readouts; a clean OS benefit would weaken the hazard-ratio bear case.
Source →A $115k QuantumScape long bets on Q3 progress and a November catalyst
A wallstreetbets poster disclosed 27,665 QuantumScape shares at $4.374, arguing Q3 results and new production/data-center announcements support a commercialization inflection and a pre-November 11 catalyst run-up.
$115k YOLO on $QS 27665 shares at $4.374 QuantumScape ($QS) just released its Q3 earnings yesterday, and they were significantly
It is a concentrated, dated bet on a story stock where commercialization milestones matter more than near-term earnings.
Watch Watch the November 11 catalyst and whether production/data-center claims convert into customer contracts; a delay would break the thesis.
Source →I regretted buying MXT private credit lit
Author regrets buying MXT private credit at $1.90 before it fell to $1.62 after an auditor markdown, and lists possible bailout paths.
I regretted buying MXT private credit lit I have brought at cost basis $1.90 the month just before it crashesSource →
Janus Electric's A$11m CBA facility could fund its 118-truck order book
An ASX_Bets poster holding JNS argued A$11m of CBA debt facilities can convert a 118-truck North American order book into funded production and deliveries over three to six months without an equity raise, while flagging execution, covenant and dilution risks.
JNS: A$11m in CBA facilities to fund production and deliveries – my bull case at ~45c Disclosure upfront:
It is a specific small-cap financing test: if the facility funds deliveries, the equity raise overhang shrinks; if not, dilution risk returns.
Watch Watch delivery cadence, covenant headroom and whether JNS draws the full facility before raising equity.
Source →CreditAccess Grameen's strong Q2 comes with yield and asset-quality doubts
An IndianStockMarket post decoded CreditAccess Grameen's Q2, noting 19.5% YoY AUM growth but doubts from moderating yields, slower MFI growth and rising PAR15.
Creditaccess Grameen Q2 result update and conference call decoding **Creditaccess Grameen** * 19.5% YoY AUM growth, 2.1% QoQ * 39.6%
The headline growth is not enough if microfinance yields are peaking and early delinquency is rising; it is a useful India credit bellwether.
Watch Watch PAR15 and yield trends next quarter; stabilizing asset quality would ease the bear case.
Source →Most argued
by comments per upvoteA $90k Chegg bet says cash and Busuu are worth more than the market cap
A ValueInvesting poster disclosed a roughly 90,000-share Chegg position, arguing the stock is deeply undervalued relative to cash, Busuu and legacy cash flow, with optional upside from AI data licensing and enterprise sales.
I dumped $90k into Chegg. Would Munger be proud or did I just set my money on fire?
It is a deep-value bet against AI disruption, where the key question is whether cash burn or asset value wins.
Watch Watch subscriber trends, cash burn and any AI licensing revenue; continued enrollment declines would trap the value case.
Source →GameStop's warrants expire October 30 with the $32 strike out of the money
A Superstonk post noted GameStop's publicly traded warrants expire October 30, 2026, with the $32 strike $6.61 out of the money against a $25.39 share price, and flagged the last day to sell via Computershare.
GameStop’s warrants expire in 8 days GameStop’s publicly traded warrants expire at 5:00 p.m.
The expiry removes a potential equity-linking mechanism and forces warrant holders to decide between exercising at a loss or letting them lapse.
Watch Watch the October 30 expiry and any last-minute share-price move toward $32; a close above the strike would change the exercise math.
Source →Nokia's recurring restructuring charges are undermining reported profit
An r/NOK poster argued Nokia has booked restructuring charges and write-offs every quarter since at least 2023, questioning the credibility of normalized profit and cash flow.
Restructuring Cost Are suspect IMHO Every quarter, and I stress, **EVERY QUARTER**, at least back as far as 2023 this
If 'one-time' charges are recurring, the market may be capitalizing an overstated earnings base.
Watch Watch whether Nokia excludes another restructuring charge next quarter and whether cash restructuring matches the P&L add-back.
Source →NGEN NervGen Pharma Corp.
Bullish high-conviction case on NervGen Pharma, citing NVG-291's CONNECT SCI trial results, a $61.1M cash runway through the Phase 3 RESTORE readout in 1H 2028, and large unmet need in spinal cord injury.
NGEN NervGen Pharma Corp. Here's my thoughts on $NGEN, the risk/reward setup right now is honestly one of the mostSource →
Adobe at $230 is a conditional value long against AI-disruption pessimism
A ValueInvesting post presented a conditional long on Adobe at $230, arguing its professional-workflow moat and cash generation are undervalued by AI-disruption fears.
Adobe Conditional Long at $230 per share as of Sept.
It frames the AI software debate around distribution and workflow lock-in rather than model capability.
Watch Watch net new ARR and AI monetization; accelerating seat pressure would invalidate the moat argument.
Source →